77Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions

Timári, István

Balla, Sára

Fehér, Krisztina

E. Kövér, Katalin

Szilágyi, László

MDPI

2022

QH3011 Biochemistry / biokémia

Detailed investigation of ligand–protein interactions is essential for better understanding of biological processes at the molecular level. Among these binding interactions, the recognition of glycans by lectins is of particular importance in several diseases, such as cancer; therefore, inhibition of glycan-lectin/galectin interactions represents a promising perspective towards developing therapeutics controlling cancer development. The recent introduction of 77Se NMR spectroscopy for monitoring the binding of a selenoglycoside to galectins prompted interest to optimize the sensitivity by increasing the 77Se content from the natural 7.63% abundance to 99%. Here, we report a convenient synthesis of 77Se-enriched selenodigalactoside (SeDG), which is a potent ligand of the medically relevant human galectin-3 protein, and proof of the expected sensitivity gain in 2D 1H, 77Se correlation NMR experiments. Our work opens perspectives for adding isotopically enriched selenoglycans for rapid monitoring of lectin-binding of selenated as well as non-selenated ligands and for ligand screening in competition experiments.

angol

Article

PeerReviewed

info:eu-repo/semantics/article

text

http://real.mtak.hu/150226/1/Pharmaceutics_2022_14_77SeDG_NMR_Timari_et_al.pdf

Timári, István and Balla, Sára and Fehér, Krisztina and E. Kövér, Katalin and Szilágyi, László (2022) 77Se-Enriched Selenoglycoside Enables Significant Enhancement in NMR Spectroscopic Monitoring of Glycan–Protein Interactions. PHARMACEUTICS, 14 (1). pp. 1-8. ISSN 1999-4923

http://real.mtak.hu/150226/

https://doi.org/10.3390%2Fpharmaceutics14010201

MTMT:32603044 10.3390/pharmaceutics14010201

cc_by